TF
BDSI

Tompkins Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Tompkins Financial’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-101
Closed – – 574
2020
Q4 		$0 Buy
+101
New +$389 ﹤0.01% 576

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tompkins Financial's BDSI Position: Q1 2021 in Review

Tompkins Financial sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 101 shares.

Tompkins Financial first reported a position in BDSI in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

  • Tompkins Financial reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
  • Tompkins Financial sold 101 BioDelivery Sciences International, Inc. shares in Q1 2021.
  • Tompkins Financial first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 1 quarter.
  • Tompkins Financial's BioDelivery Sciences International, Inc. position peaked at $0 in Q4 2020.
  • 151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on Tompkins Financial's 13F filing for Q1 2021, filed 9 Jun 2021.